Today: 29 April 2026
Imperial Brands share price drops nearly 2% in London trade as buyback rolls on, tobacco bill in focus
24 February 2026
1 min read

Imperial Brands share price drops nearly 2% in London trade as buyback rolls on, tobacco bill in focus

London, Feb 24, 2026, 09:24 GMT — Regular session

  • Imperial Brands slipped 1.8% at the open, erasing a slice of Monday’s advance.
  • Late Monday, the company announced it’s buying back more shares for cancellation.
  • This week, UK lawmakers kick off another round of debate over tobacco and vaping regulations.

Imperial Brands (IMB.L) dipped 1.8% to 3,241 pence right after the open in London on Tuesday, down from Monday’s 3,300 pence close. Shares kicked off the session at 3,308 pence, touching a low of 3,234 as 168,138 shares changed hands. That leaves the stock sitting nearly 3% under its Feb. 6, 52-week high of 3,341 pence.

Investors are weighing cash returns against regulatory risks as the UK’s Tobacco and Vapes Bill hits its report stage in the House of Lords this Tuesday. Lawmakers will get their chance to push through changes, picking apart the bill one clause at a time.

Tobacco shares can swing sharply, even when little’s happening. Imperial remains pegged to its dividends and buybacks, with regulation always lurking in the background.

Imperial reported Monday it bought back 597,332 ordinary shares for cancellation, paying an average of 3,264.45 pence apiece. Prices in the trades ranged from 3,219.00 to 3,296.00 pence. The company noted these purchases are part of its ongoing £1.45 billion share repurchase programme. Once settled and cancelled, Imperial will have 789,357,100 shares in issue, excluding treasury shares.

Shares of British American Tobacco (BATS.L) slipped 0.4% to 4,579 pence in early deals.

Buybacks boil down to basic math: with fewer shares in play, earnings per share get a boost—even if overall profit holds steady. Still, when sentiment sours or the only thing moving is the price itself, that won’t keep traders from putting pressure on the stock.

“Report stage” might sound technical, but markets pay close attention since it can reshape a bill in a hurry. When it comes to tobacco, amendments at this point could bring stricter marketing limits, shift how enforcement works, or push back compliance deadlines.

Politics isn’t a one-way street here. The bill might end up tougher than investors are bracing for—or it could stall out entirely. Both scenarios throw a wrench into predicting legal volumes and pricing.

Imperial has its final dividend set for March 31, with a trading update following on April 14. Traders are keeping an eye on any news emerging from the Lords debate before shifting focus to that April update, looking for a clearer sense of momentum.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Haleon PLC share price slips ahead of FY 2025 results as investors eye guidance
Previous Story

Haleon PLC share price slips ahead of FY 2025 results as investors eye guidance

Nu Holdings stock edges up premarket after 7.6% drop as Nubank earnings near
Next Story

Nu Holdings stock edges up premarket after 7.6% drop as Nubank earnings near

Go toTop